These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4632509)

  • 1. Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.
    Cooper SF; Albert JM; Hillel J; Caille G
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):73-7. PubMed ID: 4632509
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.
    Adamson L; Curry SH; Bridges PK; Firestone AF; Lavin NI; Lewis DM; Watson RD; Xavier CM; Anderson JA
    Dis Nerv Syst; 1973; 34(4):181-91. PubMed ID: 4711886
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of pattern of blood chlorpromazine and its metabolite levels and prediction of response to chlorpromazine treatment--studies on the rational pharmacotherapy in schizophrenics (author's transl)].
    Sakurai Y; Nakahara T; Ikenaga H; Takahashi R
    Seishin Shinkeigaku Zasshi; 1978 Jul; 80(7):405-24. PubMed ID: 724820
    [No Abstract]   [Full Text] [Related]  

  • 4. Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.
    Sgaragli G; Ninci R; Della Corte L; Valoti M; Nardini M; Andreoli V; Moneti G
    Drug Metab Dispos; 1986; 14(2):263-6. PubMed ID: 2870904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpatient variation and significance of plasma levels of chlorpromazine in psychotic patients.
    March JE; Donato D; Turano P; Turner WJ
    J Med; 1972; 3(3):146-62. PubMed ID: 4508254
    [No Abstract]   [Full Text] [Related]  

  • 6. Physiologic and clinical effects of chlorpromazine and their relationship to plasma level.
    Sakalis G; Curry SH; Mould GP; Lader MH
    Clin Pharmacol Ther; 1972; 13(6):931-46. PubMed ID: 5081606
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the plasma chlorpromazine level in relation to drug dosage].
    Olajossy M; Przyborowska M; Szumiło H; Misztal G
    Psychiatr Pol; 1986; 20(4):264-7. PubMed ID: 3809306
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between plasma concentrations of chlorpromazine and clinical response.
    Rivera-Calimlim L; Gift T; Nasrallah HA; Wyatt RJ; Lasagna L
    Commun Psychopharmacol; 1978; 2(3):215-22. PubMed ID: 699536
    [No Abstract]   [Full Text] [Related]  

  • 9. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP
    Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative and quantitative report on chlorpromazine and metabolites in plasma, erythrocytes and erythrocyte washings from chronically medicated schizophrenic patients.
    Turano P; March JE; Turner WJ; Merlis S
    J Med; 1972; 3(2):109-20. PubMed ID: 4507068
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha methyldopa-chlorpromazine interaction in schizophrenic patients.
    Chouinard G; Pinard G; Prenoveau Y; Tetreault L
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):60-72. PubMed ID: 4632508
    [No Abstract]   [Full Text] [Related]  

  • 12. Indications for high dose chlorpromazine therapy in chronic schizophrenia.
    Prien RF; Levine J; Cole JO
    Dis Nerv Syst; 1970 Nov; 31(11):739-45. PubMed ID: 4923151
    [No Abstract]   [Full Text] [Related]  

  • 13. Prien RF, Cole JO: High dose chlorpromazine therapy in chronic schizophrenia. Report of National Institute of Mental Health--psychopharmacology research branch collaborative study group.
    Arch Gen Psychiatry; 1968 Apr; 18(4):482-95. PubMed ID: 4868797
    [No Abstract]   [Full Text] [Related]  

  • 14. Chlorpromazine in chronic schizophrenia. The effect of age and hospitalization on behavioral dose-response relationships.
    Clark ML; Ramsey HR; Rahhal DK; Serafetinides EA; Wood FD; Costiloe JP
    Arch Gen Psychiatry; 1972 Oct; 27(4):479-83. PubMed ID: 5072717
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics.
    Freeman H
    Dis Nerv Syst; 1973; 34(6):289-93. PubMed ID: 4782285
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of thioridazine tablets to chlorpromazine spansules in the maintenance care of chronic schizophrenics.
    Bartlett C
    Curr Ther Res Clin Exp; 1971 Feb; 13(2):100-6. PubMed ID: 4994211
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlorpromazine metabolism. V. Disposition of free and conjugated metabolites in blood fractions of schizophrenic patients.
    Kaul PN; Ticku MK; Clark ML
    J Pharm Sci; 1972 Nov; 61(11):1753-7. PubMed ID: 4652645
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
    Kolakowska T; Wiles DH; McNeilly AS; Gelder MG
    Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of chlorpromazine and its metabolites in human plasma and urine by direct spectrodensitometry of thin-layer chromatograms.
    Chan TL; Sakalis G; Gershon S
    Adv Biochem Psychopharmacol; 1974; 9(0):323-33. PubMed ID: 4836209
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of response to chlorpromazine treatment in schizophrenics.
    Sakurai Y; Nakahara T; Takahashi R
    Psychopharmacologia; 1975 Oct; 44(2):195-203. PubMed ID: 1105634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.